A new AI-powered risk prediction model assists clinicians in treating cancer patients following a heart attack by combining oncology and cardiovascular data.
Key Details
- 1Researchers at University of Zurich developed ONCO-ACS, an AI-based tool for individualized risk assessment in cancer patients post-heart attack.
- 2Used data from over 1 million heart attack patients, including 47,000 with cancer, from England, Sweden, and Switzerland.
- 3Cancer patients showed a nearly 1 in 3 mortality rate within six months after a heart attack.
- 4ONCO-ACS predicts risks of death, major bleeding, or recurrent cardiac event within six months, using both cancer-related and standard cardiovascular data.
- 5The tool is validated and aims to support tailored decisions regarding catheter-based interventions and antiplatelet therapy.
Why It Matters
This is among the first AI tools designed specifically for the intersection of oncology and cardiology, addressing a major gap in risk prediction for a previously overlooked patient population. It could improve outcomes and inform personalized care strategies in radiology and broader clinical management.
Source
EurekAlert
Related News
•EurekAlert
AI-Supported Mammography Reduces Advanced Breast Cancer in Landmark Swedish Trial
AI-supported mammography screening reduces advanced breast cancer rates and improves early detection, according to the largest randomized controlled trial to date.
•EurekAlert
Large Language Models Rival Physicians in Complex Lung Cancer Decisions
A real-world study reveals that large language models (LLMs) can match or exceed human physicians' performance in challenging lung cancer case decision-making, especially for rare cases.
•EurekAlert
Intelligent Medicine Journal Rises in International Influence Rankings
Intelligent Medicine ranks 66th in China's top internationally influential journals, reflecting its impact in AI-driven clinical research.